We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toA-New-Way-of-Authoring-and-Reviewing-Documents-for-Clinical-Development

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

A New Way of Authoring and Reviewing Documents for Clinical Development

    Session Chair(s)
      David  Twomey

      David Twomey

      • Director, Scientific Informatics Systems
      • Novartis Institute for Biomedical Research, United States
    Historically, the clinical document writing process is error prone due to human error and its use of old technology, which does not integrate well with all the systems used in clinical trials. By automating and integrating clinical authoring, we improve both accuracy and efficiency, and leverage information across clinical business systems. The result is higher overall quality and consistency, more timely document authoring, and rapid knowledge sharing across departments. This session will describe how various companies have solved this problem. One solution was to create a cloud-based software solution for authoring, reviewing, and approving clinical trial documents. The Collaborative Authoring Tool (CAT) integrates many downstream systems to automate the transfer of content and enables the re-use of standard language to improve quality and consistency
    Learning Objective : Describe custom software that facilitates the collaborative authoring, reviewing, and approval of clinical documents.